Elevated levels of BCAAs selectively disrupt mitochondrial pyruvate utilization and promote MS, whereas promoting BCAA catabolism or normalizing glucose utilization by overexpressing GLUT1 in the heart can rescue the metabolism disorder (Li et al., 2017). This evidence concerns the gene SLC2A1 and metabolic disease.